Hugo_Symbol Entrez_Gene_Id Center NCBI_Build Chromosome Start_position End_position Strand Variant_Classification Variant_Type Reference_Allele Tumor_Seq_Allele1 Tumor_Seq_Allele2 dbSNP_RS dbSNP_Val_Status Tumor_Sample_Barcode Matched_Norm_Sample_Barcode Match_Norm_Seq_Allele1 Match_Norm_Seq_Allele2 Tumor_Validation_Allele1 Tumor_Validation_Allele2 Match_Norm_Validation_Allele1 Match_Norm_Validation_Allele2 Verification_Status Validation_Status Mutation_Status Sequencing_Phase Sequence_Source Validation_Method Score BAM_file Sequencer Tumor_Sample_UUID Matched_Norm_Sample_UUID Genome_Change Annotation_Transcript Transcript_Strand Transcript_Exon Transcript_Position cDNA_Change Codon_Change Protein_Change Other_Transcripts Refseq_mRNA_Id Refseq_prot_Id SwissProt_acc_Id SwissProt_entry_Id Description UniProt_AApos UniProt_Region UniProt_Site UniProt_Natural_Variations UniProt_Experimental_Info GO_Biological_Process GO_Cellular_Component GO_Molecular_Function COSMIC_overlapping_mutations COSMIC_fusion_genes COSMIC_tissue_types_affected COSMIC_total_alterations_in_gene Tumorscape_Amplification_Peaks Tumorscape_Deletion_Peaks TCGAscape_Amplification_Peaks TCGAscape_Deletion_Peaks DrugBank ref_context gc_content CCLE_ONCOMAP_overlapping_mutations CCLE_ONCOMAP_total_mutations_in_gene CGC_Mutation_Type CGC_Translocation_Partner CGC_Tumor_Types_Somatic CGC_Tumor_Types_Germline CGC_Other_Diseases DNARepairGenes_Role FamilialCancerDatabase_Syndromes MUTSIG_Published_Results OREGANNO_ID OREGANNO_Values t_alt_count t_ref_count validation_alt_allele validation_method validation_status validation_tumor_sample pox qox pox_cutoff isArtifactMode oxoGCut PAK7 57144 broad.mit.edu 37 20 9523285 9523285 + Missense_Mutation SNP G G A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr20:9523285G>A ENST00000378429.3 - 10 2498 c.1952C>T c.(1951-1953)gCg>gTg p.A651V PAK7_ENST00000378423.1_Missense_Mutation_p.A651V|PAK7_ENST00000353224.5_Missense_Mutation_p.A651V NM_020341.3 NP_065074.1 Q9P286 PAK7_HUMAN p21 protein (Cdc42/Rac)-activated kinase 7 651 Protein kinase. ATP binding|protein binding|protein serine/threonine kinase activity NS(1)|central_nervous_system(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(10)|lung(44)|ovary(2)|skin(13)|stomach(1)|upper_aerodigestive_tract(3) 81 COAD - Colon adenocarcinoma(9;0.194) CCTCCGCATCGCCTGGAGGGG 0.507000 34 81 0 0 1 0 0 DIDO1 11083 broad.mit.edu 37 20 61511261 61511261 + Missense_Mutation SNP G G A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr20:61511261G>A ENST00000266070.4 - 16 6372 c.6047C>T c.(6046-6048)cCg>cTg p.P2016L DIDO1_ENST00000395343.1_Missense_Mutation_p.P2016L NM_033081.2 NP_149072.2 Q9BTC0 DIDO1_HUMAN death inducer-obliterator 1 2016 Pro-rich. apoptosis|transcription, DNA-dependent cytoplasm|nucleus zinc ion binding NS(6)|breast(5)|central_nervous_system(1)|cervix(3)|endometrium(6)|kidney(1)|large_intestine(17)|lung(39)|ovary(8)|prostate(3)|skin(7)|stomach(2)|upper_aerodigestive_tract(1) 99 Breast(26;5.68e-08) CATCACCTGCGGGGCCTGGCC 0.687000 4 158 0 0 1 0 0 AC008103.5 0 broad.mit.edu 37 22 18846020 18846020 + RNA SNP T T C rs1064861 TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr22:18846020T>C ENST00000412938.1 + 0 3378 TCACTGACGTTGAAGGCTGCC 0.637000 3 34 0 0 1 0 0 MUC17 140453 broad.mit.edu 37 7 100677874 100677874 + Silent SNP G G A rs147962629 byFrequency TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr7:100677874G>A ENST00000306151.4 + 3 3241 c.3177G>A c.(3175-3177)acG>acA p.T1059T NM_001040105.1 NP_001035194.1 Q685J3 MUC17_HUMAN mucin 17, cell surface associated 1059 59 X approximate tandem repeats.|Ser-rich. extracellular region|integral to membrane|plasma membrane extracellular matrix constituent, lubricant activity p.T1059T(1) NS(3)|breast(14)|central_nervous_system(2)|cervix(2)|endometrium(27)|haematopoietic_and_lymphoid_tissue(2)|kidney(18)|large_intestine(28)|lung(179)|ovary(19)|pancreas(1)|prostate(13)|skin(26)|stomach(2)|upper_aerodigestive_tract(3)|urinary_tract(4) 343 Lung NSC(181;0.136)|all_lung(186;0.182) GTTCTGAAACGAGCACACTTT 0.502000 7 558 0 0 1 0 0 TPTE2P6 0 broad.mit.edu 37 13 25144710 25144710 + RNA SNP A A G rs71218558 by1000genomes TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr13:25144710A>G ENST00000453498.1 + 0 251 GATGTGTTTAACACAGCCCCT 0.398000 3 27 0 0 1 0 0 BCAN 63827 broad.mit.edu 37 1 156626790 156626790 + Missense_Mutation SNP C C A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr1:156626790C>A ENST00000329117.4 + 10 2447 c.2111C>A c.(2110-2112)tCc>tAc p.S704Y BCAN_ENST00000496038.1_3'UTR|RP11-284F21.7_ENST00000448869.1_RNA NM_021948.4 NP_068767.3 Q96GW7 PGCB_HUMAN brevican 704 C-type lectin. cell adhesion anchored to membrane|proteinaceous extracellular matrix hyaluronic acid binding|sugar binding cervix(1)|endometrium(6)|kidney(3)|large_intestine(6)|lung(29)|ovary(3)|pancreas(1)|prostate(2)|skin(2)|upper_aerodigestive_tract(2) 55 all_hematologic(923;0.088)|Hepatocellular(266;0.158) AAGCACTTTTCCACACGAAGG 0.627000 18 30 5.3912e-06 6.23688e-06 1 1 0 DNAH5 1767 broad.mit.edu 37 5 13923453 13923453 + Missense_Mutation SNP C C A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr5:13923453C>A ENST00000265104.4 - 4 478 c.374G>T c.(373-375)gGg>gTg p.G125V NM_001369.2 NP_001360.1 Q8TE73 DYH5_HUMAN dynein, axonemal, heavy chain 5 125 Stem (By similarity). microtubule-based movement cilium axoneme|cytoplasm|microtubule ATP binding|ATPase activity|microtubule motor activity p.G125V(1) NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8) 378 Lung NSC(4;0.00476) CACACATACCCCAGTAAGAGC 0.473000 Kartagener syndrome 4 201 0.00909568 0.00941483 1 1 0 CAMKK2 10645 broad.mit.edu 37 12 121678617 121678617 + Missense_Mutation SNP C C T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr12:121678617C>T ENST00000324774.5 - 17 2480 c.1652G>A c.(1651-1653)gGa>gAa p.G551E CAMKK2_ENST00000347034.2_Missense_Mutation_p.G508E|CAMKK2_ENST00000337174.3_Missense_Mutation_p.E537K|CAMKK2_ENST00000402834.4_Missense_Mutation_p.G551E|CAMKK2_ENST00000538733.1_Missense_Mutation_p.E494K|CAMKK2_ENST00000404169.3_Missense_Mutation_p.G551E|CAMKK2_ENST00000392474.2_Intron|CAMKK2_ENST00000412367.2_Missense_Mutation_p.E537K|CAMKK2_ENST00000545538.1_Intron NM_006549.3 NP_006540.3 Q96RR4 KKCC2_HUMAN calcium/calmodulin-dependent protein kinase kinase 2, beta 551 calcium-mediated signaling|MAPKKK cascade|positive regulation of transcription, DNA-dependent|protein autophosphorylation|regulation of protein kinase activity cytoplasm ATP binding|calcium ion binding|calmodulin binding|calmodulin-dependent protein kinase activity|protein tyrosine kinase activity endometrium(2)|kidney(1)|large_intestine(2)|liver(2)|lung(4)|prostate(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(2) 17 all_neural(191;0.0684)|Medulloblastoma(191;0.0922) AGCACTTCCTCCTCCCCCACG 0.647000 15 39 0 0 1 0 0 CACNA1G 8913 broad.mit.edu 37 17 48649291 48649291 + Silent SNP C C T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr17:48649291C>T ENST00000352832.5 + 5 1011 c.639C>T c.(637-639)aaC>aaT p.N213N CACNA1G_ENST00000354983.4_Silent_p.N213N|CACNA1G_ENST00000416767.4_Silent_p.N213N|CACNA1G_ENST00000429973.2_Silent_p.N213N|CACNA1G_ENST00000442258.2_Silent_p.N213N|CACNA1G_ENST00000510115.1_Silent_p.N213N|CACNA1G_ENST00000502264.1_Silent_p.N213N|CACNA1G_ENST00000503485.1_Silent_p.N213N|CACNA1G_ENST00000514717.1_Silent_p.N213N|CACNA1G_ENST00000512389.1_Silent_p.N213N|CACNA1G_ENST00000515165.1_Silent_p.N213N|CACNA1G_ENST00000513964.1_Silent_p.N213N|CACNA1G_ENST00000513689.2_Silent_p.N213N|CACNA1G_ENST00000507609.1_Silent_p.N213N|CACNA1G_ENST00000514079.1_Silent_p.N213N|CACNA1G_ENST00000514181.1_Silent_p.N213N|CACNA1G_ENST00000505165.1_Silent_p.N213N|CACNA1G_ENST00000515765.1_Silent_p.N213N|CACNA1G_ENST00000515411.1_Silent_p.N213N|CACNA1G_ENST00000358244.5_Silent_p.N213N|CACNA1G_ENST00000510366.1_Silent_p.N213N|CACNA1G_ENST00000360761.4_Silent_p.N213N|CACNA1G_ENST00000359106.5_Silent_p.N213N|CACNA1G_ENST00000507510.2_Silent_p.N213N|CACNA1G_ENST00000507336.1_Silent_p.N213N|CACNA1G_ENST00000507896.1_Silent_p.N213N NM_001256334.1|NM_198376.2|NM_198379.2|NM_198387.2|NM_198388.2 NP_001243263.1|NP_938190.1|NP_938193.1|NP_938201.1|NP_938202.1 O43497 CAC1G_HUMAN calcium channel, voltage-dependent, T type, alpha 1G subunit 213 axon guidance voltage-gated calcium channel complex low voltage-gated calcium channel activity breast(5)|cervix(1)|endometrium(13)|kidney(5)|lung(23) 47 Breast(11;6.7e-17) BRCA - Breast invasive adenocarcinoma(22;7.52e-09) Ethosuximide(DB00593)|Flunarizine(DB04841)|Levetiracetam(DB01202)|Mibefradil(DB01388)|Pimozide(DB01100)|Trimethadione(DB00347)|Verapamil(DB00661)|Zonisamide(DB00909) TGCTGGGCAACGTCCTGCTGC 0.617000 24 52 0 0 1 0 0 ZBTB46 140685 broad.mit.edu 37 20 62422012 62422012 + Silent SNP G G T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr20:62422012G>T ENST00000245663.4 - 2 249 c.99C>A c.(97-99)gtC>gtA p.V33V ZBTB46_ENST00000395104.1_Silent_p.V33V|ZBTB46_ENST00000302995.2_Silent_p.V33V NM_025224.3 NP_079500.2 Q86UZ6 ZBT46_HUMAN zinc finger and BTB domain containing 46 33 BTB. regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus nucleic acid binding|zinc ion binding endometrium(2)|kidney(1)|large_intestine(9)|lung(9)|ovary(1)|skin(1)|upper_aerodigestive_tract(1) 24 all_cancers(38;2.09e-12)|all_epithelial(29;3.8e-14)|Lung NSC(23;7.61e-10)|all_lung(23;2.64e-09) CGACCACGCAGACGTCGCACA 0.587000 7 30 0.000274275 0.000294222 1 1 0 KIR3DL1 3811 broad.mit.edu 37 19 55331320 55331320 + Missense_Mutation SNP C C A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr19:55331320C>A ENST00000391728.4 + 4 541 c.508C>A c.(508-510)Cag>Aag p.Q170K KIR3DL1_ENST00000402254.2_Missense_Mutation_p.Q170K|KIR3DL1_ENST00000326542.7_Missense_Mutation_p.Q170K|KIR3DL1_ENST00000358178.4_Missense_Mutation_p.Q75K|KIR3DL1_ENST00000541392.1_Missense_Mutation_p.Q170K|KIR3DL1_ENST00000538269.1_Missense_Mutation_p.Q170K NM_013289.2 NP_037421.2 killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 breast(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|ovary(2)|skin(1)|upper_aerodigestive_tract(1) 11 GBM - Glioblastoma multiforme(193;0.0192) CCTCGTTGGACAGATCCATGA 0.517000 5 272 0.0215528 0.0219244 1 1 0 ADAMTS7 11173 broad.mit.edu 37 15 79060504 79060504 + Missense_Mutation SNP C C A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr15:79060504C>A ENST00000388820.4 - 17 2826 c.2616G>T c.(2614-2616)agG>agT p.R872S ADAMTS7_ENST00000566303.1_5'UTR NM_014272.3 NP_055087.2 Q9UKP4 ATS7_HUMAN ADAM metallopeptidase with thrombospondin type 1 motif, 7 872 TSP type-1 2. proteolysis proteinaceous extracellular matrix metalloendopeptidase activity|zinc ion binding NS(1)|breast(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(2)|lung(23)|ovary(1)|prostate(8)|skin(9) 54 CGCTGCACTTCCTCTGTTGGT 0.697000 3 9 6.4e-05 7.12453e-05 1 1 0 EPPK1 83481 broad.mit.edu 37 8 144940742 144940742 + Missense_Mutation SNP G G A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr8:144940742G>A ENST00000525985.1 - 2 6751 c.6680C>T c.(6679-6681)gCg>gTg p.A2227V P58107 EPIPL_HUMAN epiplakin 1 2227 cytoplasm|cytoskeleton protein binding|structural molecule activity NS(1)|autonomic_ganglia(1)|breast(1)|central_nervous_system(5)|cervix(1)|endometrium(8)|kidney(4)|large_intestine(2)|lung(30)|ovary(2)|pancreas(1)|prostate(10)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(1) 71 all_cancers(97;1.42e-10)|all_epithelial(106;1.99e-09)|Lung NSC(106;0.000126)|all_lung(105;0.000354)|Ovarian(258;0.0173)|Acute lymphoblastic leukemia(118;0.155) OV - Ovarian serous cystadenocarcinoma(54;2.46e-41)|Epithelial(56;2.88e-40)|all cancers(56;1.82e-35)|Colorectal(110;0.055)|BRCA - Breast invasive adenocarcinoma(115;0.105) CAGGACGCCCGCGATGCAGCT 0.677000 4 165 0 0 1 0 0 PHLDB1 23187 broad.mit.edu 37 11 118516368 118516368 + Splice_Site SNP G G A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr11:118516368G>A ENST00000361417.2 + 17 3827 c.3416_splice c.e17+1 p.S1139_splice PHLDB1_ENST00000356063.5_Splice_Site_p.S1092_splice|PHLDB1_ENST00000527898.1_Splice_Site_p.S190_splice|PHLDB1_ENST00000524713.1_Splice_Site_p.S282_splice|PHLDB1_ENST00000534672.1_3'UTR NM_015157.3 NP_055972.1 Q86UU1 PHLB1_HUMAN pleckstrin homology-like domain, family B, member 1 1139 breast(3)|cervix(1)|endometrium(5)|kidney(3)|large_intestine(10)|liver(3)|lung(14)|ovary(2)|pancreas(1)|prostate(3)|skin(1) 46 all_hematologic(175;0.0839) Medulloblastoma(222;0.0523)|all_hematologic(192;0.0735)|all_neural(223;0.224) BRCA - Breast invasive adenocarcinoma(274;3.4e-05) AACATGTCCAGGTACACCCGA 0.637000 31 66 0 0 1 0 0 LL22NC03-80A10.6 0 broad.mit.edu 37 22 22664141 22664141 + RNA SNP G G A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr22:22664141G>A ENST00000426066.1 + 0 664 NR_027293.1 AAATTTGAAGGTGCTGTGATT 0.448000 4 82 0 0 1 0 0 DIP2A 23181 broad.mit.edu 37 21 47918601 47918601 + Silent SNP C C T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr21:47918601C>T ENST00000318711.7 + 5 693 c.510C>T c.(508-510)gtC>gtT p.V170V DIP2A_ENST00000435722.3_Silent_p.V170V|DIP2A_ENST00000466639.1_Silent_p.V170V|DIP2A_ENST00000427143.2_Silent_p.V106V|DIP2A_ENST00000417564.2_Silent_p.V170V|DIP2A_ENST00000400274.1_Silent_p.V170V|DIP2A_ENST00000457905.3_Silent_p.V170V NM_001146116.1|NM_015151.3 NP_001139588.1|NP_055966.2 Q14689 DIP2A_HUMAN DIP2 disco-interacting protein 2 homolog A (Drosophila) 170 multicellular organismal development nucleus catalytic activity|transcription factor binding cervix(1)|endometrium(7)|kidney(2)|large_intestine(6)|lung(22)|ovary(3)|upper_aerodigestive_tract(1)|urinary_tract(1) 43 Breast(49;0.0933) Epithelial(3;3.12e-06)|OV - Ovarian serous cystadenocarcinoma(3;5.68e-06)|all cancers(3;4.08e-05)|Colorectal(79;0.0129)|COAD - Colon adenocarcinoma(84;0.0824) TCGACCGGGTCATTCAGGGCT 0.667000 6 91 0 0 1 0 0 PSME4 23198 broad.mit.edu 37 2 54128611 54128611 + Missense_Mutation SNP G G A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr2:54128611G>A ENST00000404125.1 - 28 3216 c.3161C>T c.(3160-3162)cCa>cTa p.P1054L PSME4_ENST00000421748.2_Missense_Mutation_p.P198L NM_014614.2 NP_055429.2 Q14997 PSME4_HUMAN proteasome (prosome, macropain) activator subunit 4 1054 anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process|apoptosis|cell differentiation|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|M/G1 transition of mitotic cell cycle|mRNA metabolic process|multicellular organismal development|positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|regulation of apoptosis|regulation of cellular amino acid metabolic process|S phase of mitotic cell cycle|spermatogenesis|viral reproduction nuclear speck|proteasome complex binding breast(5)|endometrium(8)|kidney(1)|large_intestine(11)|lung(26)|ovary(4)|pancreas(1)|prostate(1)|stomach(1)|urinary_tract(2) 60 Lung(47;0.125)|LUSC - Lung squamous cell carcinoma(58;0.181) AACAATCGCTGGCCACGTCTG 0.438000 65 112 0 0 1 0 0 FAM27L 284123 broad.mit.edu 37 17 21825433 21825433 + RNA SNP G G A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr17:21825433G>A ENST00000426869.3 + 0 137 NR_028336.1 family with sequence similarity 27-like central_nervous_system(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(2)|lung(7)|prostate(1) 14 UCEC - Uterine corpus endometrioid carcinoma (53;0.11)|BRCA - Breast invasive adenocarcinoma(1;0.00463) ccgaggctccggcctgacttc 0.622000 9 18 0 0 1 0 0 RP11-423O2.5 0 broad.mit.edu 37 1 142803543 142803543 + RNA SNP C C T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr1:142803543C>T ENST00000423385.1 - 0 1422 TGTTGGAATTCCTGATGAATC 0.269000 4 137 0 0 1 0 0 NBEA 26960 broad.mit.edu 37 13 36223967 36223967 + Missense_Mutation SNP G G T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr13:36223967G>T ENST00000540320.1 + 51 8417 c.7883G>T c.(7882-7884)aGa>aTa p.R2628I NBEA_ENST00000400445.3_Missense_Mutation_p.R2628I|NBEA_ENST00000379939.2_Missense_Mutation_p.R2625I|NBEA_ENST00000310336.4_Missense_Mutation_p.R2628I|NBEA_ENST00000537702.1_Missense_Mutation_p.R421I|NBEA_ENST00000379922.3_Missense_Mutation_p.R206I Q8NFP9 NBEA_HUMAN neurobeachin 2628 cytosol|endomembrane system|plasma membrane|trans-Golgi network protein binding NS(1)|breast(1)|endometrium(14)|kidney(4)|large_intestine(29)|lung(40)|ovary(9)|prostate(3)|skin(1)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(3) 108 Breast(139;0.0141)|Lung SC(185;0.0548)|Prostate(109;0.207) all cancers(112;1.93e-08)|Epithelial(112;1.62e-07)|BRCA - Breast invasive adenocarcinoma(63;0.00033)|OV - Ovarian serous cystadenocarcinoma(117;0.00109)|KIRC - Kidney renal clear cell carcinoma(186;0.00575)|Kidney(163;0.00656)|GBM - Glioblastoma multiforme(144;0.191)|Lung(94;0.199) GCAGTGAATAGATGGCACAAC 0.448000 18 54 5.35267e-07 6.31615e-07 1 1 0 RGS6 9628 broad.mit.edu 37 14 72976895 72976895 + Nonsense_Mutation SNP G G A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr14:72976895G>A ENST00000553530.1 + 14 1206 c.999G>A c.(997-999)tgG>tgA p.W333* RGS6_ENST00000434263.2_Nonsense_Mutation_p.W264*|RGS6_ENST00000404301.2_Nonsense_Mutation_p.W333*|RGS6_ENST00000553525.1_Nonsense_Mutation_p.W333*|RGS6_ENST00000407322.4_Nonsense_Mutation_p.W333*|RGS6_ENST00000406236.4_Nonsense_Mutation_p.W333*|RGS6_ENST00000355512.6_Nonsense_Mutation_p.W333*|RGS6_ENST00000402788.2_Nonsense_Mutation_p.W333*|RGS6_ENST00000555571.1_Nonsense_Mutation_p.W333*|RGS6_ENST00000554782.1_Nonsense_Mutation_p.W194*|RGS6_ENST00000556437.1_Nonsense_Mutation_p.W333*|RGS6_ENST00000343854.6_Nonsense_Mutation_p.W296* NM_001204417.1|NM_001204418.1|NM_001204420.1|NM_001204421.1|NM_001204422.1|NM_004296.5 NP_001191346.1|NP_001191347.1|NP_001191349.1|NP_001191350.1|NP_001191351.1|NP_004287.3 P49758 RGS6_HUMAN regulator of G-protein signaling 6 333 G-protein coupled receptor protein signaling pathway|intracellular signal transduction|negative regulation of signal transduction|regulation of G-protein coupled receptor protein signaling pathway cytoplasm|heterotrimeric G-protein complex GTPase activator activity|signal transducer activity endometrium(2)|kidney(3)|large_intestine(6)|lung(14)|prostate(2)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1) 33 all cancers(60;0.00309)|BRCA - Breast invasive adenocarcinoma(234;0.0281)|STAD - Stomach adenocarcinoma(64;0.0302)|OV - Ovarian serous cystadenocarcinoma(108;0.0476) TAAAAAGATGGGGCTTCTCTT 0.453000 54 89 0 0 1 0 0 IARS2 55699 broad.mit.edu 37 1 220284136 220284136 + Missense_Mutation SNP A A T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr1:220284136A>T ENST00000366922.1 + 11 1451 c.1120A>T c.(1120-1122)Atg>Ttg p.M374L IARS2_ENST00000302637.5_Missense_Mutation_p.M446L Q9NSE4 SYIM_HUMAN isoleucyl-tRNA synthetase 2, mitochondrial 446 isoleucyl-tRNA aminoacylation mitochondrial matrix ATP binding|isoleucine-tRNA ligase activity NS(1)|breast(1)|cervix(2)|endometrium(7)|kidney(4)|large_intestine(7)|lung(17)|ovary(2)|prostate(4)|skin(4)|stomach(1)|upper_aerodigestive_tract(1) 51 GBM - Glioblastoma multiforme(131;0.0554) L-Isoleucine(DB00167) AGTTATAAAGATGCTTCAGAC 0.338000 14 73 0 0 1 0 0 EXPH5 23086 broad.mit.edu 37 11 108383203 108383203 + Missense_Mutation SNP T T C TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr11:108383203T>C ENST00000265843.4 - 6 3141 c.3031A>G c.(3031-3033)Aaa>Gaa p.K1011E EXPH5_ENST00000428840.1_Missense_Mutation_p.K935E|EXPH5_ENST00000443411.1_Missense_Mutation_p.K823E|EXPH5_ENST00000525344.1_Missense_Mutation_p.K1004E NM_015065.2 NP_055880.2 Q149M6 Q149M6_HUMAN exophilin 5 1011 intracellular protein transport Rab GTPase binding breast(3)|central_nervous_system(3)|endometrium(6)|haematopoietic_and_lymphoid_tissue(2)|kidney(7)|large_intestine(13)|liver(1)|lung(34)|ovary(3)|pancreas(2)|prostate(2)|skin(11)|stomach(3)|upper_aerodigestive_tract(1) 91 all_cancers(61;3.99e-08)|Acute lymphoblastic leukemia(157;3.97e-05)|Melanoma(852;4.04e-05)|all_epithelial(67;0.000116)|all_hematologic(158;0.000315)|Breast(348;0.104)|all_neural(303;0.16) Epithelial(105;8.1e-06)|BRCA - Breast invasive adenocarcinoma(274;1.22e-05)|all cancers(92;0.000129)|OV - Ovarian serous cystadenocarcinoma(223;0.11)|Colorectal(284;0.184) TCAGAAACTTTGGAATTGCTT 0.378000 4 111 0 0 1 0 0 IDH1 3417 broad.mit.edu 37 2 209113112 209113112 + Missense_Mutation SNP C C T rs121913500 TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr2:209113112C>T ENST00000415913.1 - 4 776 c.395G>A c.(394-396)cGt>cAt p.R132H IDH1_ENST00000345146.2_Missense_Mutation_p.R132H|IDH1_ENST00000446179.1_Missense_Mutation_p.R132H O75874 IDHC_HUMAN isocitrate dehydrogenase 1 (NADP+), soluble 132 R -> C (in colorectal cancer and glioma samples; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha- ketoglutarate but instead alpha- ketoglutarate is converted to R(-)-2- hydroxyglutarate).|R -> G (in a glioma sample; glioblastoma multiforme; somatic mutation).|R -> H (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> L (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> S (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate). 2-oxoglutarate metabolic process|cellular lipid metabolic process|glyoxylate cycle|isocitrate metabolic process|NADPH regeneration|tricarboxylic acid cycle cytosol|peroxisomal matrix isocitrate dehydrogenase (NADP+) activity|magnesium ion binding|NAD binding|protein homodimerization activity p.R132H(2774)|p.R132L(59)|p.R132V(1)|p.G131_R132>VL(1) NS(1)|autonomic_ganglia(2)|biliary_tract(24)|bone(237)|central_nervous_system(3764)|endometrium(3)|haematopoietic_and_lymphoid_tissue(794)|kidney(2)|large_intestine(7)|lung(7)|prostate(6)|skin(5)|soft_tissue(12)|thyroid(22)|urinary_tract(1) 4887 Epithelial(149;0.0322)|LUSC - Lung squamous cell carcinoma(261;0.0711)|Lung(261;0.136) ATAAGCATGACGACCTATGAT 0.393000 Mis gliobastoma 31 64 0 0 1 0 0 IGHV1OR21-1 0 broad.mit.edu 37 21 10862768 10862768 + RNA SNP C C G TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr21:10862768C>G ENST00000559480.1 + 0 64 breast(1)|endometrium(1)|kidney(3)|lung(20)|urinary_tract(1) 26 GTCCCAGGTACAGCTGGTGCA 0.547000 37 297 0 0 1 0 0 XPC 7508 broad.mit.edu 37 3 14220007 14220007 + Missense_Mutation SNP G G C TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr3:14220007G>C ENST00000285021.7 - 1 276 c.62C>G c.(61-63)tCc>tGc p.S21C XPC_ENST00000449060.2_Missense_Mutation_p.S21C|LSM3_ENST00000306024.3_5'UTR NM_001145769.1|NM_004628.4 NP_001139241.1|NP_004619.3 Q01831 XPC_HUMAN xeroderma pigmentosum, complementation group C 21 nucleotide-excision repair, DNA damage recognition|nucleotide-excision repair, DNA damage removal cytoplasm|nucleoplasm|XPC complex bubble DNA binding|damaged DNA binding|loop DNA binding|protein binding|single-stranded DNA binding NS(1)|breast(2)|endometrium(1)|kidney(3)|large_intestine(4)|lung(5)|ovary(3)|prostate(1)|upper_aerodigestive_tract(1)|urinary_tract(1) 22 CTTGGCCTTGGATTTCTGGCT 0.697000 """Mis, N, F, S""" """skin basal cell, skin squamous cell, melanoma""" Nucleotide excision repair (NER) Xeroderma Pigmentosum 8 56 0 0 1 0 0 ZCCHC12 170261 broad.mit.edu 37 X 117959361 117959361 + Missense_Mutation SNP G G T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chrX:117959361G>T ENST00000310164.2 + 4 661 c.154G>T c.(154-156)Gtg>Ttg p.V52L NM_173798.2 NP_776159.1 Q6PEW1 ZCH12_HUMAN zinc finger, CCHC domain containing 12 52 regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleic acid binding|zinc ion binding breast(1)|endometrium(1)|kidney(1)|large_intestine(3)|lung(13)|ovary(1)|prostate(2) 22 ctcggggagggtggtgccagc 0.552000 14 70 1.49906e-05 1.70086e-05 1 1 0 FLAD1 80308 broad.mit.edu 37 1 154965110 154965110 + Missense_Mutation SNP T T C TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr1:154965110T>C ENST00000405236.2 + 3 989 c.989T>C c.(988-990)aTg>aCg p.M330T FLAD1_ENST00000295530.2_Missense_Mutation_p.M162T|FLAD1_ENST00000368432.1_Intron|FLAD1_ENST00000368428.1_Intron|FLAD1_ENST00000292180.3_Intron|FLAD1_ENST00000315144.10_Intron Q8NFF5 FAD1_HUMAN flavin adenine dinucleotide synthetase 1 0 FAD biosynthetic process|Mo-molybdopterin cofactor biosynthetic process|water-soluble vitamin metabolic process cytosol ATP binding|FMN adenylyltransferase activity endometrium(3)|kidney(4)|large_intestine(2)|lung(7)|ovary(3)|skin(3) 22 all_epithelial(22;2.77e-30)|all_lung(78;4.1e-28)|all_hematologic(923;0.0359)|Hepatocellular(266;0.0877) BRCA - Breast invasive adenocarcinoma(34;0.00034) GAGCCATGGATGGGCCCCTTC 0.507000 22 30 0 0 1 0 0 C8orf33 65265 broad.mit.edu 37 8 146278468 146278468 + Missense_Mutation SNP A A T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr8:146278468A>T ENST00000331434.6 + 3 453 c.339A>T c.(337-339)gaA>gaT p.E113D NM_023080.2 NP_075568.1 Q9H7E9 CH033_HUMAN chromosome 8 open reading frame 33 113 endometrium(1)|large_intestine(1)|lung(4)|urinary_tract(1) 7 all_cancers(97;8.72e-12)|all_epithelial(106;1.07e-10)|Lung NSC(106;7.18e-05)|all_lung(105;0.00021)|Ovarian(258;0.0173)|Acute lymphoblastic leukemia(118;0.155) Epithelial(56;9.1e-38)|all cancers(56;7.37e-33)|BRCA - Breast invasive adenocarcinoma(115;0.0424)|Colorectal(110;0.055) GBM - Glioblastoma multiforme(99;0.243) TGGCCCAGGAATTGGCTTGGT 0.597000 14 31 0 0 1 0 0 FAM71F1 84691 broad.mit.edu 37 7 128369970 128369970 + Missense_Mutation SNP C C T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr7:128369970C>T ENST00000315184.5 + 6 921 c.868C>T c.(868-870)Cgt>Tgt p.R290C FAM71F1_ENST00000485070.1_Missense_Mutation_p.R189C NM_032599.2 NP_115988.1 Q96KD3 F71F1_HUMAN family with sequence similarity 71, member F1 290 NS(1)|breast(1)|endometrium(1)|kidney(1)|large_intestine(4)|lung(6)|prostate(1)|skin(2)|upper_aerodigestive_tract(1) 18 AGATTCTTCCCGTGAAGACAG 0.527000 5 131 0 0 1 0 0 THBS3 7059 broad.mit.edu 37 1 155171215 155171215 + Missense_Mutation SNP G G T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr1:155171215G>T ENST00000368378.3 - 11 1342 c.1322C>A c.(1321-1323)tCc>tAc p.S441Y RP11-263K19.4_ENST00000422665.1_RNA|RP11-263K19.4_ENST00000453136.1_RNA|THBS3_ENST00000487250.1_5'UTR|THBS3_ENST00000428962.2_Missense_Mutation_p.S291Y|THBS3_ENST00000541990.1_5'UTR|THBS3_ENST00000541576.1_5'UTR|THBS3_ENST00000457183.2_Missense_Mutation_p.S321Y|RP11-263K19.4_ENST00000430312.1_RNA NM_001252607.1|NM_007112.4 NP_001239536.1|NP_009043.1 P49746 TSP3_HUMAN thrombospondin 3 441 EGF-like 4. cell-matrix adhesion extracellular region|perinuclear region of cytoplasm calcium ion binding|heparin binding|structural molecule activity breast(6)|endometrium(4)|kidney(4)|large_intestine(6)|lung(14)|ovary(3)|prostate(2)|skin(2)|upper_aerodigestive_tract(4)|urinary_tract(3) 48 all_epithelial(22;5.72e-28)|all_lung(78;2.07e-24)|all_hematologic(923;0.0359)|Hepatocellular(266;0.0877) Epithelial(20;3.72e-10)|all cancers(21;1.19e-09)|BRCA - Breast invasive adenocarcinoma(34;0.000752)|LUSC - Lung squamous cell carcinoma(543;0.193) CACCTGGCAGGACACTGCACC 0.612000 6 91 0.217242 0.217242 1 1 0 SMARCC2 6601 broad.mit.edu 37 12 56558274 56558274 + Silent SNP C C T rs142435936 TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr12:56558274C>T ENST00000550164.1 - 28 3488 c.3474G>A c.(3472-3474)ccG>ccA p.P1158P SMARCC2_ENST00000394023.3_Intron|RP11-977G19.5_ENST00000553176.1_RNA|SMARCC2_ENST00000347471.4_Intron|SMARCC2_ENST00000267064.4_Silent_p.P1127P Q8TAQ2 SMRC2_HUMAN SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 1127 Pro-rich. chromatin remodeling|negative regulation of transcription, DNA-dependent|nervous system development|positive regulation of transcription, DNA-dependent|regulation of transcription from RNA polymerase II promoter|transcription, DNA-dependent nBAF complex|npBAF complex|nucleoplasm|SWI/SNF complex DNA binding|protein binding|transcription coactivator activity breast(1)|central_nervous_system(3)|endometrium(6)|kidney(3)|large_intestine(3)|lung(20)|ovary(1)|skin(2)|soft_tissue(1)|upper_aerodigestive_tract(1) 41 OV - Ovarian serous cystadenocarcinoma(18;0.123) GGAGAGTGCCCGGGGCGAACG 0.592000 7 79 0 0 1 0 0 LPHN2 23266 broad.mit.edu 37 1 82456565 82456565 + Silent SNP T T C TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr1:82456565T>C ENST00000370728.1 + 25 4761 c.4116T>C c.(4114-4116)taT>taC p.Y1372Y LPHN2_ENST00000370717.2_Silent_p.Y1387Y|LPHN2_ENST00000370727.1_Silent_p.Y1344Y|LPHN2_ENST00000335786.5_Silent_p.Y1329Y|LPHN2_ENST00000370723.1_Silent_p.Y1374Y|LPHN2_ENST00000359929.3_Silent_p.Y1316Y|LPHN2_ENST00000469377.2_3'UTR|LPHN2_ENST00000370713.1_3'UTR|LPHN2_ENST00000271029.4_Silent_p.Y1344Y|LPHN2_ENST00000370715.1_3'UTR|LPHN2_ENST00000394879.1_Silent_p.Y1374Y|LPHN2_ENST00000319517.6_Silent_p.Y1316Y|LPHN2_ENST00000370730.1_Silent_p.Y1329Y|LPHN2_ENST00000370721.1_Silent_p.Y1297Y|LPHN2_ENST00000370725.1_Silent_p.Y1387Y O95490 LPHN2_HUMAN latrophilin 2 1372 neuropeptide signaling pathway integral to membrane|plasma membrane G-protein coupled receptor activity|latrotoxin receptor activity|sugar binding NS(3)|breast(6)|central_nervous_system(1)|endometrium(7)|haematopoietic_and_lymphoid_tissue(2)|kidney(5)|large_intestine(18)|liver(2)|lung(37)|ovary(3)|pancreas(1)|prostate(3)|skin(22)|stomach(1)|upper_aerodigestive_tract(3)|urinary_tract(5) 119 all cancers(265;0.00142)|Epithelial(280;0.00829)|OV - Ovarian serous cystadenocarcinoma(397;0.077)|STAD - Stomach adenocarcinoma(256;0.248) ACTCTCTTTATACAAGCATGC 0.512000 22 43 0 0 1 0 0 ZAN 7455 broad.mit.edu 37 7 100364638 100364638 + RNA SNP G G A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr7:100364638G>A ENST00000542585.1 + 0 4766 ZAN_ENST00000427578.1_RNA|ZAN_ENST00000538115.1_RNA|ZAN_ENST00000546213.1_RNA|ZAN_ENST00000443370.1_RNA|ZAN_ENST00000348028.3_RNA|ZAN_ENST00000546292.1_RNA|ZAN_ENST00000449052.1_RNA|ZAN_ENST00000421100.1_RNA|ZAN_ENST00000349350.6_RNA NM_003386.1 NP_003377.1 Q9Y493 ZAN_HUMAN zonadhesin (gene/pseudogene) binding of sperm to zona pellucida|cell-cell adhesion integral to membrane|plasma membrane NS(2)|breast(3)|central_nervous_system(3)|endometrium(21)|kidney(6)|large_intestine(18)|lung(60)|ovary(4)|pancreas(3)|prostate(5)|skin(8)|stomach(3)|upper_aerodigestive_tract(3) 139 Lung NSC(181;0.041)|all_lung(186;0.0581) STAD - Stomach adenocarcinoma(171;0.19) CACAGGTGCCGCCACCTGCAC 0.607000 35 122 0 0 1 0 0 FGD1 2245 broad.mit.edu 37 X 54475673 54475673 + Missense_Mutation SNP G G A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chrX:54475673G>A ENST00000375135.3 - 15 2910 c.2177C>T c.(2176-2178)aCg>aTg p.T726M NM_004463.2 NP_004454.2 P98174 FGD1_HUMAN FYVE, RhoGEF and PH domain containing 1 726 actin cytoskeleton organization|apoptosis|filopodium assembly|induction of apoptosis by extracellular signals|nerve growth factor receptor signaling pathway|organ morphogenesis|regulation of Cdc42 GTPase activity|regulation of cell shape|small GTPase mediated signal transduction cytoskeleton|cytosol|Golgi apparatus|lamellipodium|nucleus|plasma membrane|ruffle metal ion binding|Rho guanyl-nucleotide exchange factor activity|small GTPase binding NS(1)|breast(2)|central_nervous_system(1)|endometrium(4)|kidney(2)|large_intestine(10)|lung(8)|ovary(3)|pancreas(1)|skin(3)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(2) 39 CCGGATGGGCGTAGGTGCCCG 0.607000 5 18 0 0 1 0 0 MYBL1 4603 broad.mit.edu 37 8 67485730 67485730 + Silent SNP T T C TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr8:67485730T>C ENST00000522677.3 - 11 1892 c.1482A>G c.(1480-1482)acA>acG p.T494T MYBL1_ENST00000517885.1_Silent_p.T152T|MYBL1_ENST00000524176.2_Silent_p.T494T NM_001080416.2|NM_001144755.1 NP_001073885.1|NP_001138227.1 P10243 MYBA_HUMAN v-myb avian myeloblastosis viral oncogene homolog-like 1 494 Negative regulatory domain (By similarity). positive regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus DNA binding breast(1)|endometrium(1)|kidney(3)|large_intestine(7)|lung(9)|ovary(2)|pancreas(1)|skin(1) 25 Epithelial(68;0.00211)|all cancers(69;0.00726)|OV - Ovarian serous cystadenocarcinoma(28;0.00989)|BRCA - Breast invasive adenocarcinoma(89;0.0938) TACCAGGACATGTGTTGAAAA 0.323000 23 18 0 0 1 0 0 DCAF12L2 340578 broad.mit.edu 37 X 125298906 125298906 + Silent SNP C C T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chrX:125298906C>T ENST00000538699.1 - 2 1082 c.1002G>A c.(1000-1002)ccG>ccA p.P334P DCAF12L2_ENST00000360028.2_Silent_p.P334P NM_001013628.2 NP_001013650.1 Q5VW00 DC122_HUMAN DDB1 and CUL4 associated factor 12-like 2 334 p.P334P(1) NS(2)|central_nervous_system(1)|cervix(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(11)|lung(36)|ovary(2)|pancreas(1)|skin(2)|upper_aerodigestive_tract(3) 64 GGCGCTGGCGCGGATCCAGGA 0.622000 41 62 0 0 1 0 0 AMOTL1 154810 broad.mit.edu 37 11 94532857 94532857 + Silent SNP G G A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr11:94532857G>A ENST00000433060.2 + 3 642 c.501G>A c.(499-501)gtG>gtA p.V167V AMOTL1_ENST00000317829.8_Silent_p.V117V|AMOTL1_ENST00000317837.9_Silent_p.V167V NM_130847.2 NP_570899.1 Q8IY63 AMOL1_HUMAN angiomotin like 1 167 cytoplasm|tight junction identical protein binding autonomic_ganglia(1)|breast(3)|central_nervous_system(1)|endometrium(2)|kidney(2)|large_intestine(14)|lung(8)|ovary(1)|pancreas(1)|prostate(1)|urinary_tract(2) 36 Acute lymphoblastic leukemia(157;2.38e-05)|all_hematologic(158;0.00824) AACACCAGGTGGACAATACGG 0.527000 10 25 0 0 1 0 0 TRBV5-4 0 broad.mit.edu 37 7 142168912 142168912 + RNA SNP A A G TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr7:142168912A>G ENST00000454561.2 - 0 133 AGCCGAGTGAATTCTGGGCCT 0.582000 4 21 0 0 1 0 0 ADAMTS2 9509 broad.mit.edu 37 5 178541201 178541201 + Silent SNP G G A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr5:178541201G>A ENST00000251582.7 - 22 3404 c.3303C>T c.(3301-3303)aaC>aaT p.N1101N NM_014244.4 NP_055059.2 O95450 ATS2_HUMAN ADAM metallopeptidase with thrombospondin type 1 motif, 2 1101 collagen catabolic process proteinaceous extracellular matrix metalloendopeptidase activity|zinc ion binding breast(1)|cervix(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(15)|lung(31)|ovary(1)|pancreas(3)|prostate(2)|skin(7) 72 all_cancers(89;0.000456)|all_epithelial(37;0.000138)|Renal(175;0.000159)|Lung NSC(126;0.00184)|all_lung(126;0.00326) all_cancers(40;0.00604)|all_neural(177;0.00411)|Medulloblastoma(196;0.00508)|Lung NSC(249;0.0569)|all_lung(500;0.129)|all_hematologic(541;0.211) Kidney(164;2.23e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000178) GBM - Glioblastoma multiforme(465;0.0473) TGCCCTCCACGTTGGTGAGGT 0.547000 4 38 0 0 1 0 0 CAMKMT 79823 broad.mit.edu 37 2 44931420 44931420 + Splice_Site SNP A A C TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr2:44931420A>C ENST00000378494.3 + 4 420 c.e4-1 NM_024766.3 NP_079042.1 Q7Z624 CMKMT_HUMAN calmodulin-lysine N-methyltransferase cytoplasm calmodulin-lysine N-methyltransferase activity breast(2)|large_intestine(3)|lung(5) 10 TGTGTTTTCTAGGCATCTGGC 0.348000 11 70 0 0 1 0 0 CCT6P3 0 broad.mit.edu 37 7 64531401 64531401 + RNA SNP C C T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr7:64531401C>T ENST00000426828.1 + 0 1209 NR_033416.1 TTTGCTGATGCGTTGCTCGTT 0.438000 4 41 0 0 1 0 0 TLL1 7092 broad.mit.edu 37 4 166924714 166924714 + Silent SNP C C A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr4:166924714C>A ENST00000061240.2 + 6 1451 c.804C>A c.(802-804)atC>atA p.I268I TLL1_ENST00000507499.1_Silent_p.I268I|TLL1_ENST00000513213.1_Silent_p.I268I NM_012464.4 NP_036596.3 O43897 TLL1_HUMAN tolloid-like 1 268 Metalloprotease (By similarity). cell differentiation|proteolysis|skeletal system development extracellular region calcium ion binding|metalloendopeptidase activity|zinc ion binding NS(1)|breast(1)|central_nervous_system(1)|endometrium(7)|kidney(4)|large_intestine(21)|lung(26)|ovary(2)|prostate(5)|skin(6)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1) 77 all_hematologic(180;0.221) Melanoma(52;0.0315)|Prostate(90;0.0405) GBM - Glioblastoma multiforme(119;0.103) GAGAAAACATCCAGCCAGGTG 0.383000 21 36 5.26018e-13 6.33368e-13 1 1 0 OR2D2 120776 broad.mit.edu 37 11 6913253 6913253 + Missense_Mutation SNP G G C TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr11:6913253G>C ENST00000299459.2 - 1 577 c.479C>G c.(478-480)aCc>aGc p.T160S NM_003700.1 NP_003691.1 Q9H210 OR2D2_HUMAN olfactory receptor, family 2, subfamily D, member 2 160 sensory perception of smell integral to membrane|plasma membrane olfactory receptor activity breast(1)|central_nervous_system(1)|cervix(1)|large_intestine(3)|lung(9)|ovary(1)|skin(2) 18 Medulloblastoma(188;0.0523)|all_neural(188;0.236) Epithelial(150;4.68e-08)|BRCA - Breast invasive adenocarcinoma(625;0.129) TATGAAGGTGGTGTCTACCAC 0.502000 25 22 0 0 1 0 0 LRP2 4036 broad.mit.edu 37 2 170097528 170097528 + Missense_Mutation SNP G G T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr2:170097528G>T ENST00000263816.3 - 25 4300 c.4015C>A c.(4015-4017)Ccc>Acc p.P1339T LRP2_ENST00000443831.1_Missense_Mutation_p.P1202T NM_004525.2 NP_004516.2 P98164 LRP2_HUMAN low density lipoprotein receptor-related protein 2 1339 LDL-receptor class A 15. hormone biosynthetic process|protein glycosylation|receptor-mediated endocytosis|vitamin D metabolic process coated pit|integral to membrane|lysosome calcium ion binding|receptor activity|SH3 domain binding biliary_tract(1)|breast(16)|central_nervous_system(6)|cervix(2)|endometrium(24)|haematopoietic_and_lymphoid_tissue(2)|kidney(17)|large_intestine(70)|liver(1)|lung(117)|ovary(19)|pancreas(1)|prostate(2)|skin(17)|upper_aerodigestive_tract(7)|urinary_tract(13) 315 STAD - Stomach adenocarcinoma(1183;0.000766)|COAD - Colon adenocarcinoma(177;0.0101) Gentamicin(DB00798)|Insulin Glargine recombinant(DB00047)|Insulin Lyspro recombinant(DB00046)|Insulin recombinant(DB00030)|Insulin, porcine(DB00071)|Urokinase(DB00013) GTCCCATTGGGGCAGTCAAAG 0.488000 4 60 0.00024832 0.000271313 1 1 0 TRAV3 0 broad.mit.edu 37 14 22192561 22192561 + RNA SNP G G A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr14:22192561G>A ENST00000390425.2 + 0 512 TCTGTGCTGTGAGAGACACAC 0.478000 5 21 0 0 1 0 0 ZNF234 10780 broad.mit.edu 37 19 44660574 44660574 + Silent SNP G G A TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr19:44660574G>A ENST00000426739.2 + 6 663 c.405G>A c.(403-405)agG>agA p.R135R ZNF234_ENST00000592437.1_Silent_p.R135R NM_006630.2 NP_006621.1 Q14588 ZN234_HUMAN zinc finger protein 234 135 KRNB. regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus DNA binding|zinc ion binding endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(2)|lung(11)|ovary(1)|prostate(1) 23 Prostate(69;0.0435) GCCAGGTTAGGGCAGGACTAT 0.378000 20 44 0 0 1 0 0 SSPO 23145 broad.mit.edu 37 7 149513538 149513538 + RNA SNP C C T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr7:149513538C>T ENST00000378016.2 + 0 11159 A2VEC9 SSPO_HUMAN SCO-spondin cell adhesion extracellular space peptidase inhibitor activity Melanoma(164;0.165)|Ovarian(565;0.177) OV - Ovarian serous cystadenocarcinoma(82;0.00625) GCCCACGTCACGCAGCAGGTG 0.692000 5 2 0 0 1 0 0 MYLK4 340156 broad.mit.edu 37 6 2678591 2678591 + Silent SNP C C T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr6:2678591C>T ENST00000274643.7 - 10 1245 c.903G>A c.(901-903)tcG>tcA p.S301S MYLK4_ENST00000268446.5_Silent_p.S301S NM_001012418.3 NP_001012418.2 Q86YV6 MYLK4_HUMAN myosin light chain kinase family, member 4 301 Protein kinase. ATP binding|protein serine/threonine kinase activity breast(4)|central_nervous_system(1)|cervix(1)|endometrium(1)|large_intestine(3)|lung(10)|ovary(2)|skin(1) 23 Ovarian(93;0.0412) all_hematologic(90;0.0897) CCAGGAAAGGCGACAAACCGC 0.498000 4 118 0 0 1 0 0 WSCD2 9671 broad.mit.edu 37 12 108589876 108589876 + Silent SNP C C T TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr12:108589876C>T ENST00000332082.4 + 3 1085 c.267C>T c.(265-267)taC>taT p.Y89Y WSCD2_ENST00000549903.1_Silent_p.Y89Y|WSCD2_ENST00000547525.1_Silent_p.Y89Y|WSCD2_ENST00000261400.3_Silent_p.Y89Y Q2TBF2 WSCD2_HUMAN WSC domain containing 2 89 integral to membrane breast(4)|endometrium(3)|kidney(1)|large_intestine(16)|liver(2)|lung(23)|ovary(2)|prostate(2)|skin(2)|upper_aerodigestive_tract(2) 57 CTCGCAGGTACGGACCCTGGT 0.612000 34 68 0 0 1 0 0 EVI5 7813 broad.mit.edu 37 1 92979278 92979278 + Missense_Mutation SNP T T C TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr1:92979278T>C ENST00000370331.1 - 18 2377 c.2368A>G c.(2368-2370)Agc>Ggc p.S790G EVI5_ENST00000540033.1_Missense_Mutation_p.S790G|EVI5_ENST00000543509.1_Missense_Mutation_p.S801G NM_005665.4 NP_005656.4 O60447 EVI5_HUMAN ecotropic viral integration site 5 790 Interaction with AURKB and INCENP.|Targeting to the centrosomes. cell cycle|cell division|cell proliferation|multicellular organismal development microtubule organizing center|nucleus|spindle protein binding|Rab GTPase activator activity breast(1)|endometrium(6)|kidney(2)|large_intestine(8)|lung(18)|ovary(1)|prostate(1)|skin(1) 38 all_lung(203;0.00146)|Lung NSC(277;0.00565)|all_neural(321;0.185)|Melanoma(281;0.193)|Glioma(108;0.203) Epithelial(280;8.09e-25)|OV - Ovarian serous cystadenocarcinoma(397;1.27e-22)|all cancers(265;1.74e-21)|GBM - Glioblastoma multiforme(16;0.00233)|BRCA - Breast invasive adenocarcinoma(282;0.211) ACTTGGTTGCTCTCTCTGGTC 0.488000 57 112 0 0 1 0 0 PTPN18 26469 broad.mit.edu 37 2 131129929 131129934 + In_Frame_Del DEL GACGGG GACGGG - rs112040677 TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr2:131129929_131129934delGACGGG ENST00000175756.5 + 13 1214_1219 c.1113_1118delGACGGG c.(1111-1119)cag>ca p.QTG371del PTPN18_ENST00000347849.3_In_Frame_Del_p.QTG264del NM_014369.3 NP_055184.2 Q99952 PTN18_HUMAN protein tyrosine phosphatase, non-receptor type 18 (brain-derived) 371 cytoplasm|nucleus non-membrane spanning protein tyrosine phosphatase activity p.T378_G379delTG(1) endometrium(1)|kidney(3)|large_intestine(2)|lung(5)|ovary(3)|prostate(1) 15 Colorectal(110;0.1) gtgggacgcagacggggacggggacg 0.777 3 3 --- --- --- --- ARL4A 10124 broad.mit.edu 37 7 12728279 12728282 + Frame_Shift_Del DEL AACA AACA - TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr7:12728279_12728282delAACA ENST00000396663.1 + 2 882_885 c.400_403delAACA c.(400-405)aafs p.NK134fs ARL4A_ENST00000396662.1_Frame_Shift_Del_p.NK134fs|ARL4A_ENST00000356797.3_Frame_Shift_Del_p.NK134fs|ARL4A_ENST00000396664.2_Frame_Shift_Del_p.NK134fs|ARL4A_ENST00000404894.1_Frame_Shift_Del_p.NK134fs NM_001037164.2|NM_001195396.1|NM_005738.4|NM_212460.3 NP_001032241.1|NP_001182325.1|NP_005729.1|NP_997625.1 P40617 ARL4A_HUMAN ADP-ribosylation factor-like 4A 134 small GTPase mediated signal transduction cytoplasm|nucleolus|plasma membrane GTP binding|protein binding NS(2)|lung(3)|ovary(1) 6 UCEC - Uterine corpus endometrioid carcinoma (126;0.176) TATAGTTGCTAACAAACAAGATTT 0.402 17 74 --- --- --- --- MUC6 4588 broad.mit.edu 37 11 1031058 1031059 + Splice_Site INS - - G rs140721287 by1000genomes TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr11:1031058_1031059insG ENST00000421673.2 - 6 625 c.e6-2 NM_005961.2 NP_005952.2 Q6W4X9 MUC6_HUMAN mucin 6, oligomeric mucus/gel-forming maintenance of gastrointestinal epithelium extracellular region extracellular matrix structural constituent breast(1)|central_nervous_system(1)|cervix(2)|endometrium(8)|kidney(10)|large_intestine(6)|lung(43)|ovary(4)|prostate(1)|upper_aerodigestive_tract(3)|urinary_tract(1) 80 all_cancers(49;3.3e-08)|all_epithelial(84;5.08e-05)|Breast(177;0.000307)|Ovarian(85;0.000953)|Medulloblastoma(188;0.0109)|all_neural(188;0.0299)|Lung NSC(207;0.229) all cancers(45;1.24e-24)|BRCA - Breast invasive adenocarcinoma(625;0.00031)|Lung(200;0.0576)|LUSC - Lung squamous cell carcinoma(625;0.0703) GGAACTTGCCTGGGGTGCAGAA 0.703 3 6 --- --- --- --- EMG1 10436 broad.mit.edu 37 12 7080210 7080211 + RNA INS - - G rs141646579 by1000genomes TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr12:7080210_7080211insG ENST00000546220.1 + 0 155_156 U47924.19_ENST00000564245.1_RNA|U47924.28_ENST00000261406.6_lincRNA Q92979 NEP1_HUMAN EMG1 N1-specific pseudouridine methyltransferase ribosomal small subunit biogenesis cytoplasm|nucleolus rRNA (pseudouridine) methyltransferase activity|rRNA binding CGGAGGCCGTAGTTTATTGTGG 0.569 8 17 --- --- --- --- CDKN1B 1027 broad.mit.edu 37 12 12870948 12870948 + Frame_Shift_Del DEL A A - TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr12:12870948delA ENST00000228872.4 + 1 891 c.175delA c.(175-177)agfs p.K59fs CDKN1B_ENST00000477087.1_Intron|CDKN1B_ENST00000396340.1_Frame_Shift_Del_p.K59fs NM_004064.3 NP_004055.1 P46527 CDN1B_HUMAN cyclin-dependent kinase inhibitor 1B (p27, Kip1) 59 autophagic cell death|cell cycle arrest|cellular response to lithium ion|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|G1 phase of mitotic cell cycle|G1/S transition of mitotic cell cycle|induction of apoptosis|negative regulation of cell growth|negative regulation of transcription, DNA-dependent|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of protein catabolic process|S phase of mitotic cell cycle cytosol|endosome|nucleoplasm cyclin-dependent protein kinase inhibitor activity|protein phosphatase binding|transforming growth factor beta receptor, cytoplasmic mediator activity breast(1)|large_intestine(3)|lung(3)|ovary(1)|prostate(5) 13 Prostate(47;0.0322)|all_epithelial(100;0.159) BRCA - Breast invasive adenocarcinoma(232;0.0336) GAGCCAGCGCAAGTGGAATTT 0.577 65 77 --- --- --- --- SPG20 23111 broad.mit.edu 37 13 36909272 36909272 + Frame_Shift_Del DEL A A - TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr13:36909272delA ENST00000451493.1 - 2 913 c.696delT c.(694-696)ttfs p.F232fs SPG20_ENST00000438666.2_Frame_Shift_Del_p.F232fs|SPG20_ENST00000495510.1_5'UTR|SPG20_ENST00000494062.2_Frame_Shift_Del_p.F232fs|SPG20_ENST00000355182.4_Frame_Shift_Del_p.F232fs NM_001142295.1 NP_001135767.1 Q8N0X7 SPG20_HUMAN spastic paraplegia 20 (Troyer syndrome) 232 cell death cytoplasm ubiquitin protein ligase binding breast(1)|endometrium(2)|kidney(1)|large_intestine(8)|lung(10)|prostate(2)|skin(1)|upper_aerodigestive_tract(2) 27 Breast(139;0.014)|Lung SC(185;0.0548)|Prostate(109;0.174) KIRC - Kidney renal clear cell carcinoma(5;0.119)|Kidney(79;0.169) all cancers(112;2.42e-08)|Epithelial(112;1.58e-06)|OV - Ovarian serous cystadenocarcinoma(117;0.00128)|BRCA - Breast invasive adenocarcinoma(63;0.0125)|GBM - Glioblastoma multiforme(144;0.026) CAGGATTTACAAAAAAAATCT 0.433 32 60 --- --- --- --- TP53 7157 broad.mit.edu 37 17 7577093 7577113 + In_Frame_Del DEL CGGTCTCTCCCAGGACAGGCA CGGTCTCTCCCAGGACAGGCA - rs28934574 TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr17:7577093_7577113delCGGTCTCTCCCAGGACAGGCA ENST00000420246.2 - 8 957_977 c.825_845delTGCCTGTCCTGGGAGAGACCG c.(823-846)tgg>tg p.CACPGRDR275del TP53_ENST00000269305.4_In_Frame_Del_p.CACPGRDR275del|TP53_ENST00000413465.2_Intron|TP53_ENST00000359597.4_In_Frame_Del_p.CACPGRDR275del|TP53_ENST00000455263.2_In_Frame_Del_p.CACPGRDR275del|TP53_ENST00000445888.2_In_Frame_Del_p.CACPGRDR275del NM_001126114.2|NM_001276696.1 NP_001119586.1|NP_001263625.1 P04637 P53_HUMAN tumor protein p53 275 Interaction with AXIN1 (By similarity).|Interaction with DNA.|Interaction with E4F1.|Interaction with HIPK1 (By similarity). C -> F (in sporadic cancers; somatic mutation).|C -> G (in sporadic cancers; somatic mutation).|C -> R (in sporadic cancers; somatic mutation).|C -> S (in sporadic cancers; somatic mutation).|C -> W (in sporadic cancers; somatic mutation).|C -> Y (in LFS; germline mutation and in sporadic cancers; somatic mutation). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.R282W(401)|p.R280T(65)|p.P278L(61)|p.P278S(55)|p.R280K(49)|p.G279E(32)|p.P278R(30)|p.R282G(29)|p.D281E(28)|p.R282Q(27)|p.D281N(25)|p.P278A(24)|p.C277F(24)|p.P278T(23)|p.R280G(20)|p.D281H(19)|p.R282P(17)|p.R280I(16)|p.D281Y(16)|p.R280S(15)|p.A276P(15)|p.C277Y(15)|p.P278H(13)|p.D281G(10)|p.R280fs*65(9)|p.A276S(9)|p.G279R(9)|p.R280*(8)|p.C277*(8)|p.0?(8)|p.C275W(7)|p.A276V(7)|p.A276T(7)|p.A276D(6)|p.P278fs*67(5)|p.D281V(5)|p.D281D(5)|p.C277G(5)|p.R282fs*24(4)|p.C275C(4)|p.A276G(4)|p.G279V(4)|p.C277C(4)|p.R282L(3)|p.R282H(3)|p.R282R(3)|p.R280R(3)|p.P278F(3)|p.G279G(3)|p.D281fs*63(2)|p.G279fs*27(2)|p.D281_R282>EW(2)|p.D281A(2)|p.D281>AGPY(2)|p.R280_D281delRD(2)|p.A276A(2)|p.G279fs*65(2)|p.A276fs*69(2)|p.G279W(2)|p.P278fs*28(2)|p.?(2)|p.C277W(2)|p.C277fs*29(2)|p.G279_R280delGR(1)|p.C275_A276ins10(1)|p.V274_P278del(1)|p.G279fs*59(1)|p.P278_G279insXXXXX(1)|p.D281_R282insXX(1)|p.A276_C277delAC(1)|p.F270_D281del12(1)|p.C275fs*20(1)|p.A276fs*29(1)|p.G279fs*26(1)|p.P278P(1)|p.C277_P278insXXXXXXX(1)|p.A276fs*31(1)|p.V272_K292del21(1)|p.D281R(1)|p.A276_R283delACPGRDRR(1)|p.R273_C275delRVC(1)|p.R280fs*62(1)|p.C275*(1)|p.D281fs*24(1)|p.A276fs*70(1)|p.L265_K305del41(1)|p.C275fs*67(1)|p.R282fs*63(1)|p.A276fs*64(1)|p.A276fs*68(1)|p.R283fs*62(1)|p.R282_E287delRRTEEE(1)|p.S269fs*21(1)|p.C275_R283delCACPGRDRR(1)|p.C277R(1)|p.C277S(1)|p.D281_R282delDR(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) CTCTGTGCGCCGGTCTCTCCCAGGACAGGCACAAACACGCA 0.552 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) 17 16 --- --- --- --- RRP7B 0 broad.mit.edu 37 22 42971787 42971788 + RNA DEL CA CA - TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chr22:42971787_42971788delCA ENST00000357802.2 - 0 784 GGCCTCTTTCCACAGAGTCTGG 0.663 4 6 --- --- --- --- ATRX 546 broad.mit.edu 37 X 76938929 76938929 + Frame_Shift_Del DEL C C - TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-10A-01D-A34A-08 Untested Somatic Phase_I WXS none Illumina GAIIx 233b3927-8f2f-41ab-b0d4-fe407294ee1e cf9a712f-a229-476b-9fb7-72cf76d11a37 g.chrX:76938929delC ENST00000373344.5 - 9 2033 c.1819delG c.(1819-1821)aafs p.E607fs ATRX_ENST00000395603.3_Frame_Shift_Del_p.E569fs|ATRX_ENST00000480283.1_5'UTR NM_000489.3 NP_000480.2 P46100 ATRX_HUMAN alpha thalassemia/mental retardation syndrome X-linked 607 DNA methylation|DNA recombination|DNA repair|regulation of transcription, DNA-dependent nuclear heterochromatin ATP binding|chromo shadow domain binding|DNA binding|DNA helicase activity|zinc ion binding p.?(1) bone(1)|breast(6)|central_nervous_system(31)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(15)|kidney(14)|large_intestine(1)|liver(1)|lung(40)|ovary(2)|pancreas(13)|prostate(5)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(2) 145 Phosphatidylserine(DB00144) TGTGGAACTTCCTGACAATCA 0.353 """Mis, F, N""" """Pancreatic neuroendocrine tumors, paediatric GBM""" ATR-X (alpha thalassemia/mental retardation) syndrome 173 330 --- --- --- ---